Search results

Area of interest

Area of interestAntimicrobial prescribing (3)

Type

TypeGuidance (183)Indicators (3)Local practice (2)News (33)NICE advice (22)Quality standards (5)Research recommendations (23)

Status

StatusAwaiting development (17)Discontinued (23)In development (18)Published (131)Topic selection (1)

Last updated

Last updatedLast 3 months (13)Last 6 months (19)Last year (38)Last 3 years (85)

Guidance programme

Guidance programmeAntimicrobial prescribing guidelines (3)Cancer service guidelines (1)Clinical guidelines (27)Diagnostics guidance (7)Health technology evaluations (1)Interventional procedures guidance (14)Medical technologies guidance (1)NICE guidelines (39)Public health guidelines (8)Social care guidelines (3)Technology appraisal guidance (121)

Advice programme

Advice programmeEvidence summaries (4)Medtech innovation briefings (18)

Showing 301 to 301 of 301 results for breast cancer

Sort by

Capivasertib with fulvestrant for treating hormone receptor-positive HER2-negative advanced breast cancer after endocrine treatment [ID6370]
In development [GID-TA11513] Expected publication date: 05 March 2025
Result type
Technology appraisal guidance
Status
In development

Previous page
1
…
19
20
Current page 21
Page 21 of 21

Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Knowledge resources

About NICE
Into practice
Get involved with NICE
Jobs
News
Newsletters and alerts
Contact us
Leave feedback
Reusing our content
NICE UK Open Content Licence
Syndicate our content

Facebook
Twitter
YouTube
LinkedIn

Accessibility
Freedom of information
Glossary
Terms and conditions
Privacy notice
Cookies